A New Genetic Risk Factor for
Alzheimer’s Disease
-
Peter Davies, PhD, Albert einstein
College of Medicine, litwin-Zucker Center
for research on Alzheimer’s Disease, North
Shore/lIJ Health Care System, and
- Philippe Marambaud, PhD, lIJ Medical
Center research Institute
Early Diagnosis: The Path to
Alzheimer’s Disease Prevention
- Mony de Leon, PhD, Center for Brain
Health, New York University School of
Medicine, and
- Lisa Mosconi, PhD, MS, New York
University School of Medicine
Redirecting Traffic: A New Look
at an Old Problem in Alzheimer’s
Disease
- Richard Mayeux, MD, Taub Institute for
research on Alzheimer’s Disease and the
Aging Brain, Columbia University, and
- Scott A. Small, MD, Columbia University,
School of Physicians and Surgeons
|
|
Developing New Treatments for
Alzheimer’s Disease
- Mary Sano, PhD, Alzheimer’s Disease
research Center, Mount Sinai School of
Medicine, and
- Hillel Grossman, MD, Alzheimer’s Disease
research Center, Mount Sinai School of
Medicine, Mount Sinai Memory and Aging
Center
The Role of the Alzheimer’s Amyloid
Beta Protein in the Innate Immune
System
- Rudolph E. Tanzi, PhD, Harvard Medical
School, Genetics and Aging research Unit,
MassGeneral Institute for Neurodegenerative
Disease, Massachusetts General Hospital, and
- Robert D. Moir, PhD, Harvard Medical
School, Genetics and Aging research Unit,
MassGeneral Institute for Neurodegenerative
Disease, Massachusetts General Hospital
Update on Early Diagnosis and
Prevention
- Steven H. Ferris, PhD, Alzheimer’s Disease
Center, Center of excellence on Brain Aging,
New York University langone Medical Center
Vaccination for Alzheimer’s Disease
- Thomas M. Wisniewski, MD, New York
University School of Medicine
The Amyloid Hypothesis of
Alzheimer’s — An Update for 2010
- Sam Gandy, MD, PhD, Mount Sinai School
of Medicine
Dimebon, a Promising Alzheimer’s
Drug, Elevates Brain Amyloid Levels
- John W. Steele IV, Mount Sinai School
of Medicine, Graduate School of Biological
Sciences
The Cutting Edge of Alzheimer’s
Research
- Norman R. Relkin, MD, PhD, Weill
Cornell Medical College, Weill Cornell Memory
Disorders Program
A Ruler for Shrinking Brains
- Dana W. Moore, PhD, Weill Cornell
Medical College
|